Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo-Reference-Cited by-同舟云学术

Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo

Published:1991-09 Issue:2 Volume:559 Page:352-356
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Biella G.,Panara C.,Pecile A.,Sotgiu M.L.

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference30 articles.

1. The origin, distribution and synaptic relationships of substance P axons in rat spinal cord;Barber;J. Comp. Neurol.,1979

2. Mechanisms of interaction of peptide and nonpeptide vascular neurotransmitter systems;Burnstock;J. Cardiovasc. Pharmacol.,1987

3. Substance P regulates the vasolidator activity of calcitonin gene-related peptide;Brain;Nature,1988

4. Intrathecal administration of CGRP in the rat attenuates a facilitation of the tail flick reflex induced by either substance P or noxious cutaneous stimulation;Cridland;Neurosci. Lett.,1989

5. Evidence for differential storage of calcitonin gene-related peptide, substance P and serotonin in synaptosomal vesicles of rat spinal cord;Fried;Brain Research,1989

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distribution and Chemistry of Phoenixin-14, a Newly Discovered Sensory Transmission Molecule in Porcine Afferent Neurons;International Journal of Molecular Sciences;2023-11-23

2. Migraine: Advances in the Pathogenesis and Treatment;Neurology International;2023-08-31

3. A Pharmacological Review of Calcitonin Gene-Related Peptide Biologics and Future Use for Chronic Pain;Cureus;2023-02-17

4. Migraine headache pathophysiology;Handbook of Clinical Neurology;2023

5. Glutamate in Migraine Neurobiology and Treatment;Glutamate and Neuropsychiatric Disorders;2022